His primary scientific interests are in Epitope, Antibody, Virology, Monoclonal antibody and Neutralization. His study in Epitope is interdisciplinary in nature, drawing from both Protein structure, Viral envelope, Neutralizing antibody and Conserved sequence. Michael B. Zwick combines topics linked to Glycoprotein with his work on Antibody.
Michael B. Zwick regularly links together related areas like Gp41 in his Virology studies. The Gp41 study combines topics in areas such as Epitope mapping, Phage display and Linear epitope. The study incorporates disciplines such as Molecular biology and Glycan in addition to Monoclonal antibody.
Michael B. Zwick mainly focuses on Antibody, Virology, Epitope, Glycoprotein and Gp41. Michael B. Zwick does research in Antibody, focusing on Neutralization specifically. The concepts of his Virology study are interwoven with issues in Immunology, Antigen, HIV vaccine and Monoclonal antibody.
His Epitope research is multidisciplinary, incorporating elements of Protein structure, Viral membrane and Neutralizing antibody. His work on Viral envelope as part of general Glycoprotein study is frequently connected to Envelope, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His study on Gp41 also encompasses disciplines like
Michael B. Zwick mainly investigates Antibody, Glycoprotein, Virology, Biophysics and Epitope. The study of Antibody is intertwined with the study of Virus in a number of ways. The various areas that Michael B. Zwick examines in his Glycoprotein study include Gene, Germline and Monoclonal antibody.
He has included themes like Heterologous, HIV vaccine, Liposome and Glycan in his Virology study. His Epitope study focuses on Gp41 in particular. His Gp41 research incorporates elements of Transmembrane domain and Immunogenicity.
His primary areas of investigation include Glycoprotein, Virology, Neutralization, Antibody and Gp41. His Glycoprotein research integrates issues from Biophysics, Germinal center and Liposome. His Liposome research includes themes of Viral envelope, Lipid bilayer, Immunology and Calcium flux.
As a part of the same scientific study, he usually deals with the Neutralization, concentrating on Antigenicity and frequently concerns with Neutralizing antibody, Cell sorting, Infectivity, Humoral immunity and Immune system. His Gp41 study improves the overall literature in Epitope. Michael B. Zwick has researched Glycan in several fields, including Protein structure, Receptor–ligand kinetics, Epitope mapping and Conformational epitope.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.
Erica Ollmann Saphire;Paul W. H. I. Parren;Ralph Pantophlet;Michael B. Zwick.
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.
Michael B. Zwick;Aran F. Labrijn;Meng Wang;Catherine Spenlehauer.
Journal of Virology (2001)
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Daniel A. Calarese;Christopher N. Scanlan;Michael B. Zwick;Songpon Deechongkit.
Structural definition of a conserved neutralization epitope on HIV-1 gp120.
Tongqing Zhou;Ling Xu;Barna Dey;Ann J. Hessell.
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
James M. Binley;Terri Wrin;Bette Korber;Michael B. Zwick.
Journal of Virology (2004)
Broadly Neutralizing Anti-HIV Antibody 4E10 Recognizes a Helical Conformation of a Highly Conserved Fusion-Associated Motif in gp41
Rosa M.F. Cardoso;Michael B. Zwick;Robyn L. Stanfield;Renate Kunert.
Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1
Aran F. Labrijn;Pascal Poignard;Aarti Raja;Michael B. Zwick.
Journal of Virology (2003)
A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.
Laura M. Walker;Melissa D. Simek;Frances Priddy;Johannes S. Gach.
PLOS Pathogens (2010)
Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Antibodies 2F5 and 4E10 Require Surprisingly Few Crucial Residues in the Membrane-Proximal External Region of Glycoprotein gp41 To Neutralize HIV-1
Michael B. Zwick;Richard Jensen;Sarah Church;Meng Wang.
Journal of Virology (2005)
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.
Penny L. Moore;Emma T. Crooks;Lauren Porter;Ping Zhu.
Journal of Virology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: